Due to the opposite functions of ALA and ELK1 in erythropoiesis and granulopoiesis, blocking the emergence of immature neutrophils or promoting erythrocyte differentiation in neutrophil-related AML would be beneficial for the therapy of neutrophil related AML patients. The gene discussed is ELK1; the disease is acute myeloid leukemia.